Plasminogen intravenous (ProMetic Life Sciences)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePlasminogen intravenous (ProMetic Life Sciences)
Drug Alias Nameplasminogen, human-tvmh静脉注射用xi静脉注射用血纤维蛋白溶酶原RYPLAZIM
ClassificationBiologics > Blood components
Mechanisms of ActionPlasminogen replacements
TargetsPlasminogen
Therapy Area/IndicationsType I plasminogen deficiencyCoagulation Protein Disorders
Global Approved IndicationsType I plasminogen deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/06/04
Country/TerritoryUnited StatesNorway
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPrometic Life SciencesLiminal Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesPrometic Life SciencesPrometic Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsType I plasminogen deficiency
Inactive IndicationsCoagulation Protein Disorders

Other Information

ATC CodeN/A
Related LinksN/A